Form 8-K - Current report:
SEC Accession No. 0001193125-24-283212
Filing Date
2024-12-20
Accepted
2024-12-20 16:51:59
Documents
18
Period of Report
2024-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823541d8k.htm   iXBRL 8-K 33265
2 EX-4.1 d823541dex41.htm EX-4.1 81673
3 EX-5.1 d823541dex51.htm EX-5.1 17037
4 EX-10.1 d823541dex101.htm EX-10.1 170078
5 EX-99.1 d823541dex991.htm EX-99.1 12512
9 GRAPHIC g823541dsp016.jpg GRAPHIC 7200
  Complete submission text file 0001193125-24-283212.txt   531331

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcab-20241219.xsd EX-101.SCH 2851
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcab-20241219_lab.xml EX-101.LAB 17236
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcab-20241219_pre.xml EX-101.PRE 10813
20 EXTRACTED XBRL INSTANCE DOCUMENT d823541d8k_htm.xml XML 3492
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 241568660
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)